MedPath
FDA Product

ANASTROZOLE

Product approved by U.S. Food and Drug Administration (US)

Basic Information

ANASTROZOLE

42291-016

Regulatory Information

42291-016

ANDA079220

C73584

February 6, 2023

USA

ANASTROZOLE TABLETS, USP Rx Only These highlights do not include all the information needed to use ANASTROZOLE TABLETS safely and effectively. See full prescribing information for ANASTROZOLE TABLETS. Initial U.S. Approval: 1995

HUMAN PRESCRIPTION DRUG LABEL

1

Company Information

AvKARE

796560394

Active Ingredients

LACTOSE MONOHYDRATE

Code: EWQ57Q8I5X

Class Code: IACT

POLYETHYLENE GLYCOL, UNSPECIFIED

Code: 3WJQ0SDW1A

Class Code: IACT

MAGNESIUM STEARATE

Code: 70097M6I30

Class Code: IACT

POVIDONE, UNSPECIFIED

Code: FZ989GH94E

Class Code: IACT

HYPROMELLOSE, UNSPECIFIED

Code: 3NXW29V3WO

Class Code: IACT

SODIUM STARCH GLYCOLATE TYPE A POTATO

Code: 5856J3G2A2

Class Code: IACT

TITANIUM DIOXIDE

Code: 15FIX9V2JP

Class Code: IACT

ANASTROZOLE

Quantity: 1 mg in 1 1

Code: 2Z07MYW1AZ

Class Code: ACTIB

Active Moieties

ANASTROZOLE

Code: 2Z07MYW1AZ

© Copyright 2025. All Rights Reserved by MedPath